Cargando…

Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran

BACKGROUND: Hepatitis A virus (HAV) and Hepatitis E virus (HEV) are both transmitted by the fecal-oral route and are known as the leading causes of acute viral hepatitis in the world, especially in developing countries. There is a lack of updated data on HAV and HEV seroprevalence in Iran. OBJECTIVE...

Descripción completa

Detalles Bibliográficos
Autores principales: Hesamizadeh, Khashayar, Sharafi, Heidar, Keyvani, Hossein, Alavian, Seyed Moayed, Najafi-Tireh Shabankareh, Azar, Sharifi Olyaie, Roghiyeh, Keshvari, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834187/
https://www.ncbi.nlm.nih.gov/pubmed/27110256
http://dx.doi.org/10.5812/hepatmon.32215
_version_ 1782427457389854720
author Hesamizadeh, Khashayar
Sharafi, Heidar
Keyvani, Hossein
Alavian, Seyed Moayed
Najafi-Tireh Shabankareh, Azar
Sharifi Olyaie, Roghiyeh
Keshvari, Maryam
author_facet Hesamizadeh, Khashayar
Sharafi, Heidar
Keyvani, Hossein
Alavian, Seyed Moayed
Najafi-Tireh Shabankareh, Azar
Sharifi Olyaie, Roghiyeh
Keshvari, Maryam
author_sort Hesamizadeh, Khashayar
collection PubMed
description BACKGROUND: Hepatitis A virus (HAV) and Hepatitis E virus (HEV) are both transmitted by the fecal-oral route and are known as the leading causes of acute viral hepatitis in the world, especially in developing countries. There is a lack of updated data on HAV and HEV seroprevalence in Iran. OBJECTIVES: The aim of this study was to determine the seroprevalence of HAV and HEV among a group of blood donors in Tehran, Iran. MATERIALS AND METHODS: A cross-sectional study was performed from July 2014 to December 2014, on a total of 559 blood donors referred to the Tehran blood transfusion center. The serum samples were tested for antibodies to HAV and HEV, using the enzyme-linked immunosorbent assay. RESULTS: In the present study, 536 (95.9%) cases were male and 23 (4.1%) female with mean age of 38 years. Out of 559 blood donors, 107 (19.1%) were first-time donors, 163 (29.2%) lapsed donors and 289 (51.7%) regular donors. Anti-HAV was found in 395 (70.7%) and anti-HEV in 45 (8.1%) of the blood donors. The HAV and HEV seroprevalence increased by age. There was no significant difference between genders in terms of anti-HAV and anti-HEV status. The HAV and HEV seroprevalence was significantly related to the level of education, where the donors with higher level of education had lower rate of HAV and HEV seroprevalence. The HAV and HEV seroprevalence was significantly higher in regular and lapsed donors than in first-time donors. CONCLUSIONS: The present study showed that both HAV and HEV infections are still endemic in Iran.
format Online
Article
Text
id pubmed-4834187
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-48341872016-04-22 Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran Hesamizadeh, Khashayar Sharafi, Heidar Keyvani, Hossein Alavian, Seyed Moayed Najafi-Tireh Shabankareh, Azar Sharifi Olyaie, Roghiyeh Keshvari, Maryam Hepat Mon Research Article BACKGROUND: Hepatitis A virus (HAV) and Hepatitis E virus (HEV) are both transmitted by the fecal-oral route and are known as the leading causes of acute viral hepatitis in the world, especially in developing countries. There is a lack of updated data on HAV and HEV seroprevalence in Iran. OBJECTIVES: The aim of this study was to determine the seroprevalence of HAV and HEV among a group of blood donors in Tehran, Iran. MATERIALS AND METHODS: A cross-sectional study was performed from July 2014 to December 2014, on a total of 559 blood donors referred to the Tehran blood transfusion center. The serum samples were tested for antibodies to HAV and HEV, using the enzyme-linked immunosorbent assay. RESULTS: In the present study, 536 (95.9%) cases were male and 23 (4.1%) female with mean age of 38 years. Out of 559 blood donors, 107 (19.1%) were first-time donors, 163 (29.2%) lapsed donors and 289 (51.7%) regular donors. Anti-HAV was found in 395 (70.7%) and anti-HEV in 45 (8.1%) of the blood donors. The HAV and HEV seroprevalence increased by age. There was no significant difference between genders in terms of anti-HAV and anti-HEV status. The HAV and HEV seroprevalence was significantly related to the level of education, where the donors with higher level of education had lower rate of HAV and HEV seroprevalence. The HAV and HEV seroprevalence was significantly higher in regular and lapsed donors than in first-time donors. CONCLUSIONS: The present study showed that both HAV and HEV infections are still endemic in Iran. Kowsar 2016-01-23 /pmc/articles/PMC4834187/ /pubmed/27110256 http://dx.doi.org/10.5812/hepatmon.32215 Text en Copyright © 2016, Kowsar Corp. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Hesamizadeh, Khashayar
Sharafi, Heidar
Keyvani, Hossein
Alavian, Seyed Moayed
Najafi-Tireh Shabankareh, Azar
Sharifi Olyaie, Roghiyeh
Keshvari, Maryam
Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran
title Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran
title_full Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran
title_fullStr Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran
title_full_unstemmed Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran
title_short Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran
title_sort hepatitis a virus and hepatitis e virus seroprevalence among blood donors in tehran, iran
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834187/
https://www.ncbi.nlm.nih.gov/pubmed/27110256
http://dx.doi.org/10.5812/hepatmon.32215
work_keys_str_mv AT hesamizadehkhashayar hepatitisavirusandhepatitisevirusseroprevalenceamongblooddonorsintehraniran
AT sharafiheidar hepatitisavirusandhepatitisevirusseroprevalenceamongblooddonorsintehraniran
AT keyvanihossein hepatitisavirusandhepatitisevirusseroprevalenceamongblooddonorsintehraniran
AT alavianseyedmoayed hepatitisavirusandhepatitisevirusseroprevalenceamongblooddonorsintehraniran
AT najafitirehshabankarehazar hepatitisavirusandhepatitisevirusseroprevalenceamongblooddonorsintehraniran
AT sharifiolyaieroghiyeh hepatitisavirusandhepatitisevirusseroprevalenceamongblooddonorsintehraniran
AT keshvarimaryam hepatitisavirusandhepatitisevirusseroprevalenceamongblooddonorsintehraniran